1800-272-662
Shopping Cart 0
countryflagAU
Login

BTC Health Ltd

Healthcare AU BTC

0.059AUD
-0.004(6.35%)

Last update at 2026-03-13T05:11:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.050.07
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap22.52M
  • Volume506224
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00329M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00329M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 3.98M 1.05M -10.16800M -0.57600M -0.39200M
Minority interest - - - - -
Net income 3.98M 1.05M -10.16800M -0.57600M -0.39200M
Selling general administrative 0.33M 0.32M 0.32M 0.39M 0.24M
Selling and marketing expenses 0.25M 0.30M 0.14M 0.26M 0.04M
Gross profit 0.00996M 0.02M 0.01M 0.10M 0.02M
Reconciled depreciation - - - - -
Ebit - 0.40M -10.71583M -1.06875M -0.72228M
Ebitda - 1.05M -10.16786M -0.57700M -0.39200M
Depreciation and amortization 0.67M 0.66M 0.55M 0.49M 0.33M
Non operating income net other - - - - -
Operating income -0.57646M -0.60221M -0.44700M -0.57700M -0.32950M
Other operating expenses 0.59M 1.04M 0.46M 0.67M 0.41M
Interest expense - - - 0.00064M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00996M 0.02M 9.62M 0.00064M 0.00086M
Net interest income 0.00996M 0.02M 0.01M 0.00064M 0.00086M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 1.06M -0.48796M -0.49175M -0.33028M
Total revenue 0.00996M 0.02M 0.01M 0.10M 0.02M
Total operating expenses 0.59M -1.03900M 0.46M 0.67M 0.41M
Cost of revenue - - - - -
Total other income expense net 4.56M 1.66M -9.72100M 0.00064M -0.06218M
Discontinued operations - - - - -
Net income from continuing ops 3.98M 1.06M -10.16786M -0.57608M -0.39169M
Net income applicable to common shares 3.98M 1.06M -10.16786M -0.57608M -0.39169M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 9.36M 5.15M 2.94M 13.02M 12.98M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - -2.02216M 0.00478M 0.00057M 0.00093M
Total liab 0.20M 0.20M 0.16M 0.16M 2.15M
Total stockholder equity 9.16M 4.94M 2.78M 12.86M 10.84M
Deferred long term liab - - - - -
Other current liab 0.10M - 0.15M 0.10M 2.11M
Common stock - 56.55M 55.67M 55.67M 53.27M
Capital stock 56.61M - 55.67M 55.67M 53.27M
Retained earnings -48.13586M -52.11715M -53.17244M -43.00458M -42.60036M
Other liab - - - - -
Good will - - - - -
Other assets - 5.15M - - -
Cash 0.62M 2.02M 1.74M 2.17M 2.37M
Cash and equivalents - - 1.74M 2.17M 2.37M
Total current liabilities 0.20M - 0.16M 0.16M 2.15M
Current deferred revenue - - - 0.10M 0.11M
Net debt - -2.02216M -1.73690M -2.17049M -2.36897M
Short term debt - - 0.00000M -0.05913M -0.10658M
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - -2.49317M -12.66103M -10.66525M
Property plant equipment - - - - -
Total current assets 0.64M - 1.74M 2.20M 4.98M
Long term investments 7.56M - 1.20M 10.82M 8.00M
Net tangible assets - - 2.78M 12.86M 10.84M
Short term investments - - - - 0.00000M
Net receivables - - - 0.03M 2.61M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.01M - 0.01M 0.00558M 0.04M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.51M 0.29M 0.20M 0.17M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -1.20000M -10.81989M -8.00010M
Deferred long term asset charges - - - - -
Non current assets total 8.72M - 1.20M 10.82M 8.00M
Capital lease obligations - - - - -
Long term debt total - - 0.00000M 0.00000M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.96086M -0.19780M - -2.00000M 0.50M
Change to liabilities - - 0.00614M 0.01M -0.08087M
Total cashflows from investing activities -0.96086M -0.19780M 0.00000M -2.20557M -0.01516M
Net borrowings - - - - -
Total cash from financing activities 0.06M 0.89M 0.00000M 2.40M 2.40M
Change to operating activities - - 0.02M -0.02826M 0.11M
Net income 3.98M 1.06M -10.16786M -0.57608M -0.39169M
Change in cash -1.40205M 0.29M -0.43359M -0.19848M -0.38131M
Begin period cash flow 2.02M 1.74M 2.17M 2.37M 2.75M
End period cash flow 0.62M 2.02M 1.74M 2.17M 2.37M
Total cash from operating activities -0.49998M -0.40476M -0.43361M -0.39291M -0.36615M
Issuance of capital stock 0.06M 0.89M - 2.50M -
Depreciation - - - - -
Other cashflows from investing activities -0.96087M -0.19780M 0.00000M -0.20557M -0.51516M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock 0.06M 0.89M 0.00000M -0.10000M -0.10000M
Other cashflows from financing activities - -0.19780M 0.00000M -2.20557M -0.01516M
Change to netincome - - 9.71M 0.20M 0.20M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.00397M 0.03M 0.03M -0.01777M 0.03M
Stock based compensation 0.17M - 0.09M 0.20M -
Other non cash items -4.64882M -1.49298M 9.62M 0.19M 0.08M
Free cash flow -0.49998M -0.40476M -0.43361M -0.39291M -0.36615M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BTC
BTC Health Ltd		 -0.004 6.35% 0.06 - - 6855.29 2.04 68.18 -13.3097
CSL
CSL Ltd		 -0.01 0.0071% 141.03 16.27 19.23 4.44 2.61 3.90 11.73
TLX
TELIX Pharmaceuticals Ltd		 0.06 0.53% 11.29 - 1111.11 4.73 6.52 3.77 86.30
MSB
Mesoblast Ltd		 -0.03 1.40% 2.11 - 454.55 41.58 3.42 30.11 -9.8623
NEU
Neuren Pharmaceuticals Ltd		 -0.19 1.59% 11.76 51.13 44.25 23.04 4.47 18.83 55.27

Reports Covered

Stock Research & News

View All

Profile

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. In the stem cell biology sector, the fund focuses on stem cell therapies. Within convergent technologies, it invests in biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. In the silicon biology sector, the fund focuses on structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. It invests in companies based in Australia & New Zealand. The fund invests in both listed and unlisted companies.

BTC Health Ltd

Suite 201, Camberwell, VIC, Australia, 3124

Key Executives

Name Title Year Born
Ms. Sharon Papworth C.A., B.Com., CA CFO & Company Sec. NA
Mr. Oskar Hakansson Bus. Devel. Director NA
Mr. Tim Collins Sales & Marketing Director NA
Mr. Joshua Kahanovitz Head of Finance NA
Mr. Oskar Hakansson Business Development Director NA
Ms. Tracy Weimar BA, MBA Company Secretary NA
Mr. Joshua Kahanovitz Head of Finance NA
Mr. Oskar Hakansson Business Development Director NA
Ms. Tracy Weimar BA, MBA Company Secretary NA
Mr. Joshua Kahanovitz Head of Finance NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.